CS202637B1 - Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes - Google Patents
Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes Download PDFInfo
- Publication number
- CS202637B1 CS202637B1 CS575479A CS575479A CS202637B1 CS 202637 B1 CS202637 B1 CS 202637B1 CS 575479 A CS575479 A CS 575479A CS 575479 A CS575479 A CS 575479A CS 202637 B1 CS202637 B1 CS 202637B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- furyl
- nitro
- oxadiazolyl
- substituted
- phenyl
- Prior art date
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Description
ČESKOSLOVENSKÁSOCIALISTICKÁREPUBLIKA(19 )CZECHOSLOVAKIASOCIALISTREPUBLIC (19)
POPIS VYNÁLEZUDESCRIPTION OF THE INVENTION
K AUTORSKÉMU OSVEDČENIU 202 637 »« <B1)TO CERTIFICATE 202 637 »« <B1)
W) (23) Výstavná priorita . (22) Přihlášené 24 08 79(21) PV 5754-79 (51) Int. Cl. C 07 D 413/06W) (23) Exhibition priority. (22) Entries 24 08 79 (21) PV 5754-79 (51) Int. Cl. C 07 D 413/06
ÚŘAD PRO VYNÁLEZYOFFICE OFFICE
A OBJEVY (40) Zverejnené 30 04 80(45) Vydané 01 06 83 (75)AND DISCOVERIES (40) Published 30 04 80 (45) Published 01 06 83 (75)
Autor vynálezu POVAŽANEC FRANTIŠEK ing. CSc.Author of the Invention POVAŽANEC FRANTIŠEK ing. CSc.
KOVÁČ JAROSLAV prof. ing. DrSc., BRATISLAVA (54) Sposob přípravy l-/5-nitro-2-furyl/-2-/5-substituovaných-l,3,4-oxadiazolyl/eténov 1KOVÁČ JAROSLAV prof. DrSc., BRATISLAVA (54) Preparation of 1- (5-nitro-2-furyl) -2- (5-substituted-1,3,4-oxadiazolyl) ethene 1
Vynález rieši nový sposob přípravy l-/5-nitro-2-furyl/-2-/5-sub8tituovaných-l,3»4--oxadiazolyl/eténov. Příprava l-/5-nitro-2-furyl/-2-/5-substituovaných-l,3»4-oxadiazolyl/eténov bole do-posiaí popísaná Sugiharom a Itom (Yakugaku Zasshi 85. 744 /1965/; Chem. Abstr. 63. 13240e/1965/), ktorí ich připravili cyklizáciou Ν,Ν'-disubstituovaných hydrazidov kyselin pou-žitím POClj ako dehydratačného činidla. Nevýhodou tejto metody sú dlhé reakčné Sasy. íalSia metoda, ktorá bola použitá na přípravu tejto skupiny látok, je oxidácia N--substituovaných arylidénhydrazidov kyseliny 3-/5-nitro-2-furyl/akrylovej tetraacetátomolova (Sasaki T., Yoshioka T.: Bull. Chem. Soo. Japan 42» 2989 /1970/). ModifikovanáHuisgenovu metodu použili Sugihara a Ito v japonskom patente (Fujisawa Pharmaceutical Co.Ltd. Japan 17586 /'65/; Chem. Abstr. £2, 18105a /1965/)» keň posobili na 5-substituovanétetrazoly chloridom kyseliny 3-/5-nitrofuryl/akrylovej v xyléne a získali odpovedajúce1,3,4-oxadiazoly. Hlavnou nevýhodou oboch metod sú nízké výtažky a nízká čistota produk-tov.The present invention provides a novel process for the preparation of 1- (5-nitro-2-furyl) -2- (5-substituted-1,3,4-oxadiazolyl) ethenes. Preparation of 1- (5-nitro-2-furyl) -2- (5-substituted-1,3,4-oxadiazolyl) ethene bole ethanes described by Sugihar and Itom (Yakugaku Zasshi 85, 744 (1965); Chem. Abstr) 63, 13240e (1965)) by cyclizing the cykl, Ν-disubstituted acid hydrazides using POCl 2 as a dehydrating agent. The disadvantage of this method is the long reaction Saxons. Another method used to prepare this group of compounds is the oxidation of N-substituted arylidenehydrazides of 3- (5-nitro-2-furyl / acrylic tetraacetate) (Sasaki T., Yoshioka T.: Bull. Chem. Soo. Japan 42 »2989 (1970)]. The modified Huisgen method was used by Sugihara and Ito in Japanese Patent (Fujisawa Pharmaceutical Co.Ltd. Japan 17586 ('65); Chem. Abstr. 2, 18105a / 1965), where they were placed on 5-substituted tetrazoles with 3- / 5-nitrofuryl chloride. acrylic in xylene and obtain the corresponding 1,3,4-oxadiazoles. The main disadvantage of both methods is the low yields and low product purity.
Tieto nevýhody doterajěích postupov odstraňuje nový sposob přípravy l-/5-nitro-2--furyl/-2-/5-substituovaných-l,3,4-oxadiazolyl/eténov, ktořý skracuje reakčné časy zo4 až 1 hodiny na 15 až 20 minút a súčasne poskytuje produkty vo vysokých výtažkoch. 202 637 202 037These disadvantages of the prior art are eliminated by the novel process for the preparation of 1- (5-nitro-2-furyl) -2- (5-substituted-1,3,4-oxadiazolyl) ethenes which shortens the reaction times from 4 to 1 hour to 15-20. minutes while providing products in high yields. 202 637 202 037
Syntetizované derivéty sú zaujímavé z hlediska baktericídneho a fungicídneho účinku(A. Sugihara, H. Ito: Yakugaku Zasshi 8J, 744 /1965/; Chám. Abstr. £2, 13240e /1965/)a taktiež štruktúrne patria do tej istej skupiny látok ako Furamizol, ktorý bol zavedenýako liečivo do praxe v roku 1971.Synthesized derivatives are of interest for bactericidal and fungicidal activity (A. Sugihara, H. Ito: Yakugaku Zasshi 8J, 744/1965) and also structurally belong to the same class of substances as Furamizole, which was introduced as a drug in practice in 1971.
Podstata nového sposobu přípravy l-/5-nitro-2-furyl/-2-/5-substituovanýeh-l,3,4-oxa-diazolyl/eténov podlá vynálezu spodíva v tom, že l-/5-nitro-2-furyl/-2-/5-substituované--1,3,4-oxadiazolyl/etény obecného vzorce NOj-iAccording to the invention, the novel process for the preparation of 1- (5-nitro-2-furyl) -2- (5-substituted-1,3,4-oxadiazolyl) ethanes is that 1- (5-nitro-2- furyl (2- [5-substituted-1,3,4-oxadiazolyl] ethenes of general formula (NO-1)
-OH =CH kde R je fenyl, 2-furyl, 5-/2-nitrofenyl/-2-furyl, 5-/4-brómfenyl/-2-furyl, 5-/3-chlór-fenyl/-2-furyl, 5-/2-chlórfenyl/-2-furyl a 5-/4-metoxyfenyl/-2-furyl, sa pripravujú reakciou 5-substituovaných tetrazolov obecného vzorca-OH = CH where R is phenyl, 2-furyl, 5- (2-nitrophenyl) -2-furyl, 5- (4-bromophenyl) -2-furyl, 5- (3-chlorophenyl) -2-furyl 5- (2-chlorophenyl) -2-furyl and 5- (4-methoxyphenyl) -2-furyl are prepared by reacting 5-substituted tetrazoles of the formula
NH NNH N
R _CZ'"" a H-/ I^H kde R je fenyl, 2-furyl, 5-/2-nitrofenyl/-2-furyl, 5-/4-brómfenyl/-2-furyl, 5-/3-chlór-fenyl/-2-furyl, 5-/2-ehlórfenyl/-2-furyl a 5-/4-metoxyfenyl/-2-furyl, s 3-/5-nitro-2-furyl/akryloylacetylanhydridom vzorcaAnd H- (1 H) wherein R is phenyl, 2-furyl, 5- (2-nitrophenyl) -2-furyl, 5- (4-bromophenyl) -2-furyl, 5- (3-) chloro-phenyl / -2-furyl, 5- (2-chlorophenyl) -2-furyl and 5- (4-methoxyphenyl) -2-furyl, with 3- (5-nitro-2-furyl) acryloylacetylanhydride of formula
v inertných rozpúštadlách, ako například benzénu, toluénu, o-, m-, p-xylénu, mezitylénu,pri teplotách od 70 do 140 °C. Získané substituované etylény sú vo formě čistých E izomé-rov. Výhoda sposobu podlá vynálezu spočívá okrem iného v tom, že umožňuje přípravu 1-/5--nitro-2-furyl/-2-/5-súbstituovaných-l,3,4-oxadiazolyl/eténov jednoduchým spoeobom v prie-behu 15 až 20 minút, v jednoduchosti izolácie z reakčných zmesí, vysokých výlažkoch a stá-losti a dostupnosti východzích substrátov.in inert solvents such as benzene, toluene, o-, m-, p-xylene, mesitylene, at temperatures from 70 to 140 ° C. The substituted ethylenes obtained are in the form of pure E isomers. The advantage of the process according to the invention is, inter alia, that it allows the preparation of 1- (5-nitro-2-furyl) -2- (5-substituted-1,3,4-oxadiazolyl) ethers by a simple coupling in the course of 15 to 20 minutes, in the simplicity of isolation from the reaction mixtures, the high yields and the stability and availability of the starting substrates.
Predmet vynálezu ilustrujú, ale neobmedzujú, nasledujúce příklady. Příklad 1 Příprava l-/5-nitro-2-furyl/-2-/5-fenyl-l,3,4-oxadiazolyl/eténuThe following examples illustrate, but are not limited to, the following. Example 1 Preparation of 1- (5-nitro-2-furyl) -2- (5-phenyl-1,3,4-oxadiazolyl) ethene
Zmes 1,46 g (0,01 molu) 5-fenyltetrazolu, 1,25 g (0,01 molu) 3-/5-nitro-2-furyl/-akryloylacetylanhydridu a 30 ml xylénu sa zahrieva 15 minút pri teplote 138 °C. Po ochlad-nutí reakčnej zmesi vypadnutý oxadiazol sa odsaje, přeny je etanolom a vysuSÍ. Získá sa 202 637 1,81 g (64 %) E izoméru l-/5-nitro-2-furyl/-2-/5-fenyl-l,3,4-oxadiazolyl/eténu, ktorý pokryštalizécii z etanolu mé t. t. 235 °C. Příklad 2A mixture of 1.46 g (0.01 mol) of 5-phenyltetrazole, 1.25 g (0.01 mol) of 3- (5-nitro-2-furyl) acryloylacetylanic anhydride and 30 ml of xylene was heated at 138 ° C for 15 minutes. C. After cooling the reaction mixture, the precipitated oxadiazole is filtered off with suction, washed with ethanol and dried. 202 637 1.81 g (64%) of the E isomer of 1- (5-nitro-2-furyl) -2- (5-phenyl-1,3,4-oxadiazolyl) ethene were obtained which crystallized from ethanol of m.p. ° C. Example 2
Zmes 1,36 g (0,01 molu) 5-/2-furyl/tetrazolu, 1,25 g (0,01 molu) 3-/5-nitro-2-furyl/akryloylacetylanhydridu V 30 ml toluénu sa zahrieva při teplote 100 °C 20 minút. Po ochladění reakšnej zmeai sa tuhý zvyšok odsaje. Po kryštalizécii surového oxadiazolu z etanoluzíská sa 1,36 g (50 %) l-/5-nitro-2-furyl/-2-/5-/2-furyl/-l,3,4-oxadiazolyl/eténu s t. t.206 až 208 °C. Příklad 3A mixture of 1.36 g (0.01 mol) of 5- [2-furyl / tetrazole, 1.25 g (0.01 mol) of 3- (5-nitro-2-furyl / acryloylacetylanic anhydride) in 30 ml of toluene is heated at 100 ° C for 20 minutes. After cooling the reaction mixture, the solid residue is filtered off with suction. After crystallization of the crude oxadiazole from ethanol, 1.36 g (50%) of 1- (5-nitro-2-furyl) -2- [5- (2-furyl) -1,3,4-oxadiazolyl] ethene with tt206 to 208 ° C. Example 3
Zmes 2,42 g (0,01 molu) 5- 5-/4-metoxyfenyl/-2-furyl tetrazolu, 1,25 g (0,01 molu)3-/5-nitro-2-furyl/akryloylacetylanhydridu v 30 ml benzénu sa zahrieva pošas 20 minút priteplote 80 °C. Po ochladení reakšnej zmesi tuhý zvyšok sa odsaje, premyje etanolom a kryštalizuje z monometyléteru etylénglykolu. Získá sa 2,46 g (65 %) l-/5-nitro-2-furyl/-2-/5-/5-/4-metoxyfenyl/-2-furyl/-l,3,4-oxadiazolyl/eténu s t. t. 234 až 235 °C.A mixture of 2.52 g (0.01 mole) of 5- 5- (4-methoxyphenyl) -2-furyl tetrazole, 1.25 g (0.01 mole) of 3- (5-nitro-2-furyl / acryloylacetylanic anhydride in 30) ml of benzene was heated at 80 ° C for 20 minutes. After cooling the reaction mixture, the solid residue is filtered off with suction, washed with ethanol and crystallized from ethylene glycol monomethyl ether. 2.46 g (65%) of 1- (5-nitro-2-furyl) -2- [5- (4-methoxyphenyl) -2-furyl] -1,3,4-oxadiazolyl / ethene are obtained mp 234-235 ° C.
Tabuíka 1Table 1
Fyzikálně konštanty l-/5-nitro-2-furyl/-2- ^-/5-X-2-furyl/-l,3,4-oxadiazolyl] eténov X Sumérny vzorec Molekulová hmotnost T. t. °C Výtažok % Vy počítané/s tanovené # C % H % N 2-K02CfiH4 394,30 230 až 231 55,05 2,55 14,21 C18H10N4°7 75 54,93 2,54 14,11 4-BrC6H4a 428,21 225 až 226 50,60 2,36 9,83 C18H10BrN3°5 72 50,38 2,44 9,71 3-ClC6H4b 383,75 234 až 235 56,55 2,63 10,95 C18H10C1N3°5 68 56,68 2,71 10,63 2-C1C6h4° 383,75 212 až 213 .56,55 2,63 10,95 C18»10C1N305 70 56,53 2,71 10,71 4-CH30CgH4 379,33 234 až 235 60,20 3,46 11,09 C19H13N3°6 65 60,29 3,50 10,88 Hd 273,20 206 až 208 t.t. 206-7 °C / / C12H7N3°5 50 Y® 283,23 235 až t.t. 235 °C / / G14H9N3°4 64Physical constants 1- (5-nitro-2-furyl) -2- (5-X-2-furyl) -1,4,4-oxadiazolyl] ethene X Synthesis Molecular Weight T.t.c. You calculated / calculated # C% H% N 2-K02CfiH4 394.30 230 to 231 55.05 2.55 14.21 C18H10N4 ° 7 75 54.93 2.54 14.11 4-BrC6H4a 428.21 225 to 226 50.60 2.36 9.83 C18H10BrN3 ° 5 72 50.38 2.44 9.71 3-ClC6H4b 383.75 234 to 235 56.55 2.63 10.95 C18H10C1N3 ° 5 68 56.68 2, 71 10.63 2-C1C6h4 ° 383.75 212 to 213 .56.55 2.63 10.95 C18 »10C1N305 70 56.53 2.71 10.71 4-CH30CgH4 379.33 234 to 235 60.20 3 , 46 11.09 C19H13N3 ° 6 65 60.29 3.50 10.88 Hd 273.20 206 to 208 tt 206-7 ° C (C 12 H 7 N 3 O 5 50 Y® 283.23 235 to m.p. 235 ° C / / G 14 H 9 N 3 ° 4 64
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS575479A CS202637B1 (en) | 1979-08-24 | 1979-08-24 | Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS575479A CS202637B1 (en) | 1979-08-24 | 1979-08-24 | Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes |
Publications (1)
Publication Number | Publication Date |
---|---|
CS202637B1 true CS202637B1 (en) | 1981-01-30 |
Family
ID=5403036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS575479A CS202637B1 (en) | 1979-08-24 | 1979-08-24 | Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS202637B1 (en) |
-
1979
- 1979-08-24 CS CS575479A patent/CS202637B1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2791315T3 (en) | Triazole agonists of the APJ receptor | |
EP3466955B1 (en) | Method of preparing oxazolo[4,5-b]pyridine and thiazolo[4,5-b]pyridine derivatives as irak4 inhibitors for treating cancer | |
US4639523A (en) | Aminoalkylphenoxy derivatives | |
CN102143962B (en) | Compounds having antiviral properties | |
CA3075751A1 (en) | Pyrazolopyrimidinone compounds and uses thereof | |
JP2008539185A (en) | Pyrazole compounds as prostaglandin receptor ligands | |
SK49999A3 (en) | Oxadiazole derivatives, process for their preparation and their use as medicaments | |
JP2021535207A (en) | Thyroid hormone receptor beta agonist compound | |
KR20090005195A (en) | Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors | |
TW200300679A (en) | Substituted dipheny1 heterocycles useful for treating HCV infection | |
JP2008539183A (en) | Oxazole and thiazole compounds and their use in the treatment of PGE2-mediated disorders | |
EP3704107B1 (en) | Multicyclic compounds as farnesoid x receptor modulators | |
JP2022544714A (en) | Thyroid hormone receptor beta agonist compounds | |
PT99821A (en) | Process for the preparation of novel benzoyl benzene and pharmaceutical compositions containing the same | |
BR112021007602A2 (en) | 5-membered heteroaryl carboxamide compounds for hbv treatment | |
ES2391549T3 (en) | Pyrimidodiazepinone derivative | |
EP4251625A1 (en) | Tricyclic compounds | |
BR112021015963A2 (en) | BICYCLIC COMPOUNDS SUBSTITUTED AS FARNESOID X RECEPTOR MODULATORS | |
Burch et al. | Nitrofuryl Heterocycles. III. 1 3-Alkyl-5-(5-nitro-2-furyl)-1, 2, 4-triazoles and Intermediates | |
JPH03170481A (en) | Substituted pyrimidebenzimidazole derivative | |
JP2008539181A (en) | Furan compounds useful as EP1 receptor antagonists | |
JP2022534501A (en) | tricyclic compound | |
JP2022535794A (en) | Bicyclic compounds and their use as RIP-1 kinase inhibitors | |
CS202637B1 (en) | Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes | |
CN117479934A (en) | HIPK2 inhibitors for the treatment of renal fibrosis |